PE20040420A1 - Vacunas para enfermedades reproductivas del ganado - Google Patents
Vacunas para enfermedades reproductivas del ganadoInfo
- Publication number
- PE20040420A1 PE20040420A1 PE2003000857A PE2003000857A PE20040420A1 PE 20040420 A1 PE20040420 A1 PE 20040420A1 PE 2003000857 A PE2003000857 A PE 2003000857A PE 2003000857 A PE2003000857 A PE 2003000857A PE 20040420 A1 PE20040420 A1 PE 20040420A1
- Authority
- PE
- Peru
- Prior art keywords
- virus
- leptospira
- bovine
- live modified
- influenza
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title abstract 2
- 244000144972 livestock Species 0.000 title 1
- 230000001850 reproductive effect Effects 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 6
- 241000283690 Bos taurus Species 0.000 abstract 4
- 241001518154 Leptospira kirschneri serovar Grippotyphosa Species 0.000 abstract 3
- 206010012735 Diarrhoea Diseases 0.000 abstract 2
- 241000712003 Human respirovirus 3 Species 0.000 abstract 2
- 241001550390 Leptospira interrogans serovar Canicola Species 0.000 abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract 2
- 230000000241 respiratory effect Effects 0.000 abstract 2
- 229930182490 saponin Natural products 0.000 abstract 2
- 150000007949 saponins Chemical class 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 abstract 1
- 206010057190 Respiratory tract infections Diseases 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 241001529453 unidentified herpesvirus Species 0.000 abstract 1
- 241000712461 unidentified influenza virus Species 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/265—Infectious rhinotracheitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/28011—Hepeviridae
- C12N2770/28022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Toxicology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
SE REFIERE A UNA COMPOSICION INMUNOGENICA, QUE COMPRENDE: 1)UN VIRUS HERPES BOVINO (BHV-1) VIVO MODIFICADO; 2)UN VIRUS DE PARAINFLUENZA VIVO MODIFICADO TIPO 3 (PI3); 3)UN VIRUS SINCITIAL RESPIRATORIO BOVINO (BRSV) VIVO MODIFICADO; 4)UN COADYUVANTE, QUE COMPRENDE UNA SAPONINA, UNA EMULSION EN ACEITE EN AGUA QUE CONTIENE SAPONINA Y/O QUIL A, AMPHIGEN Y COLESTEROL; 5)AL MENOS UN ANTIGENO INACTIVADO, SELECCIONADO DE: VIRUS DE LA DIARREA VIRICA BOVINA (BVD-1), LEPTOSPIRA CANICOLA, LEPTOSPIRA GRIPPOTYPHOSA, LEPTOSPIRA CANICOLA, LEPTOSPIRA GRIPPOTYPHOSA, LEPTOSPIRA BORG; Y, 6)UN VEHICULO ACEPTABLE EN VETERINARIA. LA COMPOSICION DESCRITA TIENE APLICACION PARA TRATAR O PREVENIR ENFERMEDADES O TRANSTORNOS EN UN ANIMAL, PROVOCADOS POR LA INFECCION CON EL VIRUS DE LA DIARREA VIRICA (BVDV), VIRUS SINCITIAL RESPIRATORIO BOVINO, VIRUS DE LA PARAINFLUENZA, ENTRE OTROS, QUE PROVOCAN INFECCIONES DEL SISTEMA RESPIRATORIO Y REPRODUCTOR
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40596902P | 2002-08-26 | 2002-08-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20040420A1 true PE20040420A1 (es) | 2004-07-24 |
Family
ID=31946951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000857A PE20040420A1 (es) | 2002-08-26 | 2003-08-22 | Vacunas para enfermedades reproductivas del ganado |
Country Status (31)
| Country | Link |
|---|---|
| US (4) | US20040081666A1 (es) |
| EP (2) | EP1743652B1 (es) |
| JP (4) | JP2006501237A (es) |
| KR (2) | KR20050062542A (es) |
| CN (1) | CN1315534C (es) |
| AP (1) | AP2005003238A0 (es) |
| AR (1) | AR041047A1 (es) |
| AT (1) | ATE533506T1 (es) |
| AU (2) | AU2003263390B2 (es) |
| BR (1) | BR0313806A (es) |
| CA (1) | CA2496750C (es) |
| EA (1) | EA011578B1 (es) |
| GT (1) | GT200300180A (es) |
| HR (2) | HRP20090271A2 (es) |
| IS (1) | IS7672A (es) |
| MA (1) | MA27388A1 (es) |
| ME (1) | ME00810B (es) |
| MX (1) | MXPA05002255A (es) |
| NO (1) | NO20050603L (es) |
| NZ (2) | NZ538394A (es) |
| OA (1) | OA12915A (es) |
| PA (1) | PA8581101A1 (es) |
| PE (1) | PE20040420A1 (es) |
| PL (1) | PL216541B1 (es) |
| RS (1) | RS20050177A (es) |
| TN (1) | TNSN05059A1 (es) |
| TW (1) | TWI272105B (es) |
| UA (1) | UA94689C2 (es) |
| UY (1) | UY27948A1 (es) |
| WO (1) | WO2004017990A1 (es) |
| ZA (1) | ZA200501171B (es) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7179473B2 (en) | 1998-06-05 | 2007-02-20 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
| US7135561B2 (en) | 2001-09-06 | 2006-11-14 | Boehringer Ingelheim Vetmedica Gmbh | Infectious bovine viral diarrhea virus clone |
| EP1743652B1 (en) * | 2002-08-26 | 2011-11-16 | Pfizer Products Inc. | Vaccine for respiratory and reproductive system infections in cattle |
| US20050089533A1 (en) * | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
| US7563449B2 (en) * | 2003-04-21 | 2009-07-21 | Pfizer Inc, | Methods for reducing cattle reproductive diseases |
| US7361357B2 (en) * | 2003-07-29 | 2008-04-22 | Pfizer Inc. | Safe mutant viral vaccines |
| ES2536322T3 (es) | 2003-12-17 | 2015-05-22 | Wyeth Llc | Procedimiento para producir composiciones de VSR estables en almacenamiento |
| RU2347586C2 (ru) * | 2004-04-05 | 2009-02-27 | Пфайзер Продактс Инк. | Микрофлюидизированные эмульсии типа "масло в воде" и вакцинные композиции |
| US7572455B2 (en) * | 2004-05-19 | 2009-08-11 | Boehringer Ingelheim Vetmedica Gmbh | Vaccine comprising an attenuated pestivirus |
| US20090068223A1 (en) * | 2005-11-15 | 2009-03-12 | Boehringer Ingelheim Vetmedica, Inc. | Combination vaccine comprising an attenuated bovine viral diarrhea virus |
| SI2066340T1 (sl) | 2006-09-11 | 2013-11-29 | Zoetis P Llc | Toplotno obdelani bakterini in emulzijska cepiva, pripravljena iz takih toplotno obdelanih bakterinov |
| WO2008036747A2 (en) * | 2006-09-21 | 2008-03-27 | Amarillo Biosciences, Inc. | Composition and method for immunomodulation |
| US7803527B2 (en) * | 2007-10-31 | 2010-09-28 | Novartis Ag | Inactivated bovine herpes virus-1 and methods |
| CA2710186C (en) * | 2007-12-21 | 2015-11-03 | Pfizer Inc. | Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins |
| UY31930A (es) * | 2008-06-25 | 2010-01-29 | Boheringer Ingelheim Pharma Kg | Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante |
| MX2011003535A (es) | 2008-10-03 | 2011-09-21 | Novartis Ag | Composiciones de virus de herpes bovino-1, vacunas, y metodos. |
| US8846054B2 (en) * | 2009-01-09 | 2014-09-30 | Boehringer Ingelheim Vetmedica, Inc. | Method of treating pregnant cows and/or heifers |
| RU2395299C1 (ru) * | 2009-03-31 | 2010-07-27 | Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ") | Вакцина инактивированная комбинированная против инфекционного ринотрахеита, вирусной диареи, рота-, коронавирусной болезней и лептоспироза крупного рогатого скота |
| RU2395297C1 (ru) * | 2009-03-31 | 2010-07-27 | Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ") | Вакцина инактивированная комбинированная против инфекционного ринотрахеита, вирусной диареи и лептоспироза крупного рогатого скота |
| US9364527B2 (en) * | 2011-06-10 | 2016-06-14 | Novartis Tiergesundheit Ag | Bovine vaccines and methods |
| RU2522780C2 (ru) * | 2012-07-27 | 2014-07-20 | Государственное научное учреждение Всероссийский научно-исследовательский институт ветеринарной санитарии, гигиены и экологии Российской академии сельскохозяйственных наук | Способ получения вакцины против инфекционного ринотрахеита крупного рогатого скота |
| US9314519B2 (en) | 2012-08-21 | 2016-04-19 | Intervet Inc. | Liquid stable virus vaccines |
| US20140147475A1 (en) | 2012-11-29 | 2014-05-29 | Antonius Arnoldus Christiaan Jacobs | Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida |
| US9480739B2 (en) * | 2013-03-15 | 2016-11-01 | Intervet Inc. | Bovine virus vaccines that are liquid stable |
| US9393298B2 (en) | 2013-03-15 | 2016-07-19 | Intervet Inc. | Liquid stable bovine virus vaccines |
| HUE048344T2 (hu) | 2013-03-18 | 2020-08-28 | Intervet Int Bv | Vakcina kérõdzõ védelmére Mannheimia haemolytica okozta tüdõgyulladás ellen |
| AR097762A1 (es) | 2013-09-27 | 2016-04-13 | Intervet Int Bv | Formulaciones secas de vacunas que son estables a temperatura ambiente |
| AR099470A1 (es) | 2014-02-17 | 2016-07-27 | Intervet Int Bv | Vacunas de virus de aves de corral líquidas |
| TWI670085B (zh) | 2014-02-19 | 2019-09-01 | 荷蘭商英特威國際公司 | 液體穩定之豬病毒疫苗 |
| EP3402878A1 (en) | 2016-01-11 | 2018-11-21 | Zoetis Services LLC | Novel cross protective vaccine compositions for porcine epidemic diarrhea virus |
| BR112018069371A2 (pt) | 2016-03-21 | 2019-01-22 | South Dakota Board Of Regents | construção de ácido nucleico, vetor, vacina ou composição imunogênica, método de entrega de uma vacina, método de produção de uma construção de ácido nucleico e método para conferir imunidade contra um antígeno |
| PL3522871T3 (pl) | 2016-10-05 | 2022-02-14 | Zoetis Services Llc | Sposoby liofilizacji, które zapewniają stabilne odwodnione pierwotniaki do zastosowania jako silne żywe szczepionki |
| RU2643335C1 (ru) * | 2016-11-14 | 2018-01-31 | Федеральное государственное бюджетное образовательное учреждение высшего образования Санкт-Петербургская государственная академия ветеринарной медицины (ФГБОУ ВПО СПбГ АВМ) | Инактивированная бивалентная гидроокись алюминиевая вакцина против кампилобактериоза собак |
| GB201703529D0 (en) | 2017-03-06 | 2017-04-19 | Cambridge Entpr Ltd | Vaccine composition |
| CN110317749B (zh) * | 2019-06-19 | 2021-01-22 | 山东省农业科学院奶牛研究中心 | 一株牛支原体强毒株及其应用 |
| RU2764220C1 (ru) * | 2020-12-02 | 2022-01-14 | Федеральное государственное бюджетное научное учреждение "Краснодарский научный центр по зоотехнии и ветеринарии" ФГБНУ КНЦЗВ | Способ предупреждения риска заболевания парагриппом-3 у телят |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3634587A (en) * | 1969-11-06 | 1972-01-11 | Ralston Purina Co | Method of immunizing cattle against bovine respiratory disease syndrome |
| BE759425A (fr) * | 1969-11-28 | 1971-05-25 | Mebus Charles A | Vaccins contre la diarrhee du veau, leur preparation et emploi |
| US5593873A (en) | 1986-01-27 | 1997-01-14 | Syntro Corporation | Recombinant infectious bovine rhinotracheitis virus |
| US5084269A (en) | 1986-11-06 | 1992-01-28 | Kullenberg Fred W | Adjuvant for dose treatment with antigens |
| EP0273512B1 (en) * | 1986-12-19 | 1991-02-27 | Duphar International Research B.V | Stabilised adjuvant suspension comprising dimethyl dioctadecyl ammonium bromide |
| US6291228B1 (en) * | 1988-08-03 | 2001-09-18 | Vericore Limited | Vaccine |
| GB8818415D0 (en) * | 1988-08-03 | 1988-09-07 | Animal Health Inst | Vaccine |
| MX9301736A (es) | 1992-03-30 | 1994-01-31 | Smithkline Beecham Corp | Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1. |
| US5951988A (en) * | 1993-03-30 | 1999-09-14 | University Of Saskatchewan | Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods |
| EP0725831A1 (en) | 1993-11-05 | 1996-08-14 | PHARMACIA & UPJOHN COMPANY | Viral vector with bovine viral diarrhea virus (bvdv) antigens |
| NZ285324A (en) * | 1994-05-10 | 1998-08-26 | American Home Prod | Vaccine containing modified live bovine respiratory syncytial virus (brsv) with an adjuvant and pharmaceutically acceptable carrier |
| US5709865A (en) | 1994-11-10 | 1998-01-20 | Biostar Inc. | Immunogenic composition against Bovine Viral Diarrhea Virus II glycoprotein 53 (BVDV-II gp53) |
| US6001613A (en) | 1996-05-24 | 1999-12-14 | Board Of Regents Of University Of Nebraska | Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid |
| US6060457A (en) | 1996-06-20 | 2000-05-09 | Universite De Montreal | DNA plasmid vaccine for immunization of animals against BVDV |
| BR9803232A (pt) * | 1997-08-26 | 2000-01-11 | Pfizer Prod Inc | Vaicna de neospora. |
| AU1145699A (en) * | 1997-09-05 | 1999-03-22 | Smithkline Beecham Biologicals (Sa) | Oil in water emulsions containing saponins |
| UA78180C2 (uk) * | 1997-10-03 | 2007-03-15 | Меріаль | Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти |
| EP0924295A3 (en) * | 1997-12-04 | 2001-05-16 | Pfizer Products Inc. | DNA encoding neospora dihydrofolate reductase-thymidylate synthase |
| WO1999055366A1 (en) | 1998-04-24 | 1999-11-04 | Washington University | Chimeras of hepatitis c virus and bovine viral diarrhea virus |
| AU769539B2 (en) * | 1999-01-29 | 2004-01-29 | Zoetis Services Llc | Adjuvants for use in vaccines |
| EP1743652B1 (en) * | 2002-08-26 | 2011-11-16 | Pfizer Products Inc. | Vaccine for respiratory and reproductive system infections in cattle |
| WO2008107908A1 (en) | 2007-03-05 | 2008-09-12 | Cadila Healthcare Limited | Compositions comprising peg- interferon alpha conjugates and raffinose as cryoprotectant |
-
2003
- 2003-08-14 EP EP06122758A patent/EP1743652B1/en not_active Expired - Lifetime
- 2003-08-14 RS YUP-2005/0177A patent/RS20050177A/sr unknown
- 2003-08-14 JP JP2004530459A patent/JP2006501237A/ja active Pending
- 2003-08-14 WO PCT/IB2003/003633 patent/WO2004017990A1/en not_active Ceased
- 2003-08-14 OA OA1200500058A patent/OA12915A/en unknown
- 2003-08-14 ME MEP-2009-213A patent/ME00810B/me unknown
- 2003-08-14 HR HR20090271A patent/HRP20090271A2/xx not_active Application Discontinuation
- 2003-08-14 AP AP2005003238A patent/AP2005003238A0/xx unknown
- 2003-08-14 AU AU2003263390A patent/AU2003263390B2/en not_active Expired
- 2003-08-14 BR BR0313806-2A patent/BR0313806A/pt not_active Application Discontinuation
- 2003-08-14 PL PL375548A patent/PL216541B1/pl unknown
- 2003-08-14 HR HRP20050192AA patent/HRP20050192B1/hr not_active IP Right Cessation
- 2003-08-14 NZ NZ538394A patent/NZ538394A/en not_active IP Right Cessation
- 2003-08-14 UA UAA200501771A patent/UA94689C2/ru unknown
- 2003-08-14 KR KR1020057003230A patent/KR20050062542A/ko not_active Ceased
- 2003-08-14 CN CNB038203162A patent/CN1315534C/zh not_active Expired - Lifetime
- 2003-08-14 EA EA200500275A patent/EA011578B1/ru not_active IP Right Cessation
- 2003-08-14 NZ NZ565206A patent/NZ565206A/en not_active IP Right Cessation
- 2003-08-14 KR KR1020067022893A patent/KR20060116037A/ko not_active Ceased
- 2003-08-14 EP EP03792580A patent/EP1536830A1/en not_active Ceased
- 2003-08-14 MX MXPA05002255A patent/MXPA05002255A/es active IP Right Grant
- 2003-08-14 AT AT06122758T patent/ATE533506T1/de active
- 2003-08-14 CA CA2496750A patent/CA2496750C/en not_active Expired - Lifetime
- 2003-08-20 TW TW092122872A patent/TWI272105B/zh not_active IP Right Cessation
- 2003-08-22 PE PE2003000857A patent/PE20040420A1/es not_active Application Discontinuation
- 2003-08-22 UY UY27948A patent/UY27948A1/es not_active Application Discontinuation
- 2003-08-25 PA PA20038581101A patent/PA8581101A1/es unknown
- 2003-08-25 AR ARP030103054A patent/AR041047A1/es unknown
- 2003-08-25 GT GT200300180A patent/GT200300180A/es unknown
- 2003-08-26 US US10/647,919 patent/US20040081666A1/en not_active Abandoned
-
2005
- 2005-01-27 IS IS7672A patent/IS7672A/is unknown
- 2005-02-03 NO NO20050603A patent/NO20050603L/no not_active Application Discontinuation
- 2005-02-09 ZA ZA200501171A patent/ZA200501171B/en unknown
- 2005-02-25 MA MA28121A patent/MA27388A1/fr unknown
- 2005-02-25 TN TNP2005000059A patent/TNSN05059A1/fr unknown
-
2007
- 2007-08-30 US US11/897,421 patent/US20070298053A1/en not_active Abandoned
-
2008
- 2008-12-16 AU AU2008258154A patent/AU2008258154B2/en not_active Expired
-
2009
- 2009-05-15 JP JP2009118662A patent/JP2009215309A/ja not_active Withdrawn
-
2010
- 2010-06-22 US US12/820,566 patent/US9662384B2/en active Active
-
2011
- 2011-12-16 JP JP2011275303A patent/JP5785073B2/ja not_active Expired - Lifetime
-
2012
- 2012-12-28 US US13/729,206 patent/US20130129779A1/en not_active Abandoned
-
2015
- 2015-06-03 JP JP2015113008A patent/JP2015172069A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20040420A1 (es) | Vacunas para enfermedades reproductivas del ganado | |
| UY28274A1 (es) | Metodos para prevenir enfermedades reproductivas en el ganado vacuno | |
| AR042935A1 (es) | Vacunas caninas contra bordetella bronchiseptica | |
| AR066405A1 (es) | Vacuna | |
| MX2009006178A (es) | Vacuna contra salmonela. | |
| ECSP056189A (es) | Composiciones y método para el tratamiento de infecciones en ganado vacuno y porcino | |
| AR040204A1 (es) | Composicion de vacuna meningococica multivalente | |
| CO5700790A2 (es) | Composiciones de vacuna que comprenden una interleucina 18 y sistema de adyuvante de saponina | |
| AR007862A1 (es) | Vacuna bovina, su uso y kit de vacunación que la contiene. | |
| MX2007004133A (es) | Vacunas caninas multivalentes contra leptospira bratislava y otros patogenos. | |
| CL2008003845A1 (es) | Vacuna que comprende una emulsion, una bacterina tratada termicamente a 55-70°c por 5-10 horas, que comprende una suspension de bacterias muertas de la especie leptospira bratislava, y de 1 a 13 virus causantes de enfermedad porcina. | |
| CO6361950A2 (es) | Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1 | |
| AR054844A1 (es) | Vacuna contra lawsonia y metodos de uso de la misma | |
| CO5690616A2 (es) | Vacunas para enfermedades reproductoras del ganado | |
| AR048671A1 (es) | Procedimiento de vacunacion contra la infeccion testicular por bvdv | |
| DOP2003000699A (es) | Vacunas para enfermedades reproductoras del ganado | |
| RU2010120755A (ru) | Вакцина, ассоциированная против парвовирусной, реовирусной, герпесвирусной типа i инфекций и вирусной диареи - болезни слизистых оболочек крупного рогатого скота, инактивированная эмульсионная | |
| AR056753A1 (es) | Vacuna de primera dosis -refuerzo para la proteccion de equinos contra la influenza equina | |
| AR042035A1 (es) | Uso de rmlt como antigeno marcador para vacunas y como un aditivo sinergico con amphigen | |
| AR084225A1 (es) | Composiciones y metodos para vacunar ganado vacuno | |
| Burgess et al. | RECENT DEVELOPMENTS IN VACCINATION FOR PORCINE PARVO VIRUS | |
| ES2172482B1 (es) | Adicion de la patente es200100402 "vacuna para la proteccion de perros frente a la leishmania". | |
| BR0107771A (pt) | Vacinação contra o vìrus do herpes canino e vacinas | |
| TH91790A (th) | วัคซีนรวม ซึ่งประกอบด้วยไวรัสก่อการท้องเสียของสัตว์จำพวกวัว ที่ถูกทำให้อ่อนกำลังลง | |
| TH77205B (th) | วัคซีนรวม ซึ่งประกอบด้วยไวรัสก่อการท้องเสียของสัตว์จำพวกวัว ที่ถูกทำให้อ่อนกำลังลง |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |